Cara Therapeutics | CARA - EPS Earnings Per Share

Stock Price
3.10
Daily Change
-0.05 -1.59%
Monthly
-2.52%
Yearly
-87.82%
Q2 Forecast
3.03

Cara Therapeutics reported $-0.59 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Assertio Holdings USD -0.03 0.01 Sep/2024
Cara Therapeutics USD -0.59 4.45 Sep/2025
Cassava Sciences USD -0.26 0.04 Dec/2025
Chugai Pharma JPY 70.13 7.9 Mar/2026
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.29 0.11 Mar/2026
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Pacira USD 0.6 0.54 Mar/2026
Pfizer USD 0.66 0.21 Dec/2025
RedHill Biopharma USD -1.31 33.38 Jun/2024
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024